Caffeine citrate treatment for extremely premature infants with apnea: population pharmacokinetics, absolute bioavailability, and implications for therapeutic drug monitoring (Q46213578)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Caffeine citrate treatment for extremely premature infants with apnea: population pharmacokinetics, absolute bioavailability, and implications for therapeutic drug monitoring |
scientific article |
Statements
1 reference
Caffeine citrate treatment for extremely premature infants with apnea: population pharmacokinetics, absolute bioavailability, and implications for therapeutic drug monitoring (English)
1 reference
Bruce G Charles
1 reference
Sarah R Townsend
1 reference
Peter A Steer
1 reference
Andrew Shearman
1 reference
1 December 2008
1 reference
30
1 reference
6
1 reference
709-716
1 reference